Suzie Ferreira, Ph.D.

Prior to joining Volastra, Suzie worked in Drug Metabolism and Pharmacokinetics (DMPK) at Corbus Pharmaceuticals, Inc in discovery and early development of small molecule projects and mAbs in immuno-oncology.  Before Corbus, Suzie established and grew the DMPK group for Charles River Laboratories (South San Francisco) focused on in vivo PK and Bioanalysis. Preceding Charles River, Suzie served as a senior investigator on various disease area projects and as in vivo PK head at Novartis Institute for Biomedical Research (DMPK). Prior to Novartis, Suzie was at Pfizer Global R&D in the Pharmacokinetics Dynamics and Metabolism group.

Suzie completed an industrial postdoctoral at Novartis preceded by an academic postdoc at University of Illinois at Urbana-Champaign. She received her Ph.D. from Kent State University and a B.Sc and M.Sc from The University of Bombay.